As of 2025-09-16, the Fair Value of TherapeuticsMD Inc (TXMD) is -0.99 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.08 USD, the upside of TherapeuticsMD Inc is -191.83%.
With the market price of 1.08 USD and our fair value calculation, TherapeuticsMD Inc (TXMD) is not a good investment. Investing in TXMD stocks now will result in a potential loss of 191.83%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -183.52 | -172.42 | 112.00 | -10.28 | -2.18 | -51.28 |
| YoY growth | -4.18% | 6.05% | 164.96% | -109.18% | 78.78% | 27.29% |
| Market Cap (mil) | 12.50 |
| P/E | |
| Forward P/E |
| EPS | -0.04 |
| Avg earnings growth rate | 27.29% |
| TTM earnings | -0.46 |